Li, Ying
Talbot, Chad Lamar
Chandravanshi, Bhawna
Ksiazek, Alec
Sood, Ayushi
Chowdhury, Kamrul Hasan
Maschek, J. Alan
Cox, James
Babu, Adhini Kuppuswamy Satheesh
Paz, Henry A.
Babu, Pon Velayutham Anandh
Meyerholz, David K.
Wankhade, Umesh D.
Holland, William
Shyong Tai, E.
Summers, Scott A.
Chaurasia, Bhagirath
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK115824, DK124326, DK108833)
U.S. Department of Agriculture (2019-67018-29250)
ADA Foundation (7-21-JDF-033)
Juvenile Diabetes Research Foundation United States of America (JDRF 3-SRA- 581 2019-768-A-B)
Article History
Received: 23 December 2021
Accepted: 20 April 2022
First Online: 4 May 2022
Competing interests
: SAS is a consultant and shareholder with Centaurus Therapeutics.